EClinicalMedicine·14 SepEffects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trialRandomised trial in 164 peopleEarPaper
Advanced Science·10 SepCo-Delivery of Sustained Release Chondroitinase ABC-37 With Human iPSC-Derived Neural Progenitors Promotes Transplant Survival and Functional Recovery in a Rodent Model of StrokeExperiments in animalsInterventionsPaper
Alzheimer's & Dementia·9 SepMore efficient screening for preclinical Alzheimer's clinical trials using mixture of expertsTrial in peopleAlzheimer's diseasePaper
AAIC 2025 Abstract·26 DecDIAN‐TU‐001 Trial (Tau NexGen) Rationale and Enrollment ExperienceTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecDevelopment of Subcutaneous Lecanemab: Establishing the Comparability of Subcutaneous and Intravenous Lecanemab FormulationsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·25 DecSafety of Lecanemab After 6‐Month Treatment in the DIAN‐TU‐001 TrialTrial in peopleInterventionsPaper
AAIC 2025 Abstract·25 DecLecanemab in DIAD: 6‐Month Amyloid PET Results from the DIAN‐TU‐001 TrialTrial in peopleInterventionsPaper
AAIC 2025 Abstract·25 DecLecanemab Subcutaneous Formulation for Maintenance Dosing in Early Alzheimer’s Disease (AD)Computational studyInterventionsPaper
AAIC 2025 Abstract·25 DecBeyond A Single Study Visit: Lesson Learned from the AD Clinical TrialsComputational studyInterventionsPaper
AAIC 2025 Abstract·23 DecHearing Loss and Cognition Among Older Adults in the Longitudinal Aging Study in India‐Diagnostic Assessment of Dementia (LASI‐DAD) StudyStudy in peoplePopulationsPaper